Guidelines recommend patients undergoing a first pacemaker implant who have even mild
left ventricular (LV) impairment should receive biventricular or conduction system pacing …

Abstract Background and Aims De novo implanted cardiac resynchronization therapy with
defibrillator (CRT-D) reduces the risk of morbidity and mortality in patients with left bundle …

In the last years, major progress has occurred in heart failure (HF) management. The 2023
ESC focused update of the 2021 HF guidelines introduced new key recommendations …

Aim Cardiac resynchronization therapy (CRT) is a cornerstone in the management of
chronic heart failure in patients with a broad or paced QRS. However, data on long‐term …

Device therapy for heart failure has rapidly evolved over 2 decades. The knowledge of
indications, assessment lead and device technology has expanded to include CRT, leadless …

Aims Recommendations on cardiac resynchronization therapy (CRT) in patients with atrial
fibrillation or flutter (AF) are based on less robust evidence than those in sinus rhythm (SR) …

Aims Late gadolinium enhancement (LGE) assessed by cardiovascular magnetic resonance
(CMR) can evaluate myocardial scar associated with a higher risk of sudden cardiac death …

Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in patients with
heart failure (HF) with reduced ejection fraction (HFrEF) and electrical dyssynchrony but …

Abstract Background In the BUDAPEST (Biventricular Upgrade on left ventricular reverse
remodeling and clinical outcomes in patients with left ventricular Dysfunction and intermittent …

Cardiac Resynchronization Therapy (CRT) is an established technique to improve morbidity
and mortality in selected heart failure patients. This technique has been a game changer for …